Article By:
Rick Ristov
Wednesday, December 22, 2021 7:23 AM EDT
Regulatory approvals from FDA and EUA and growing investment and policy support from governments worldwide forecast a bright outlook for the biotech industry in the long run.
In this article: REGN, BIIB, EXEL, UTHR Also: FBT, SPY
